BVX Insider Trading Activity and SEC Form 4 Filings
BVX insider trading summary
No open-market insider purchases or sales of BOVIE MEDICAL Corp (BVX) have been reported on SEC Form 4 in the past 12 months.
Latest BVX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2016 | John J. McCarthy III | Chief CommercializationOfficer | Buy | $299K (90,750 @ $3.30) |
| Dec 22, 2015 | John J. McCarthy III | Chief Commercialization Office | Buy | $49K (25,000 @ $1.98) |
| Dec 21, 2015 | Robert Gershon | Chief Executive Officer | Buy | $18K (10,000 @ $1.82) |
| Dec 21, 2015 | Moshe Citronowicz | Sr. V.P. of Operations | Buy | $37K (20,000 @ $1.84) |
| Aug 14, 2015 | Robert Gershon | Chief Executive Officer | Buy | $48K (20,000 @ $2.39) |
| Dec 23, 2011 | Gregory Alan Konesky | Director | Sell | $2K (750 @ $2.40) |
| Aug 25, 2011 | RENN Universal Growth Investment Trust | Director | Buy | $19K (7,100 @ $2.70) |
| Aug 24, 2011 | RENN Universal Growth Investment Trust | Director | Buy | $38K (14,100 @ $2.66) |
| Aug 23, 2011 | RENN Universal Growth Investment Trust | Director | Buy | $30K (11,600 @ $2.55) |
| Aug 9, 2011 | RENN Universal Growth Investment Trust | 10% Owner | Buy | $31K (15,000 @ $2.09) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.